TP53 and adrenal cortex carcinoma: Germline mutations of TP53 characterize 50–80% of children with ACC and 4% of adult patients; on the other hand, somatic mutations of TP53 are observed in more than 50% of adult ACC patients, associated with a more aggressive phenotype [5,6].